Pharmabiz
 

Himalaya Drug Company introduces novel oral rinse ‘Oro-T’ for cancer patients

Our Bureau, BengaluruThursday, November 30, 2017, 16:50 Hrs  [IST]

The Himalaya Drug Company, has now introduced  a novel herbal medicine, Oro-T, an advanced mouth rinse with turmeric powder for cancer patients.

Oro-T, a polyherbal formulation, is a first-of-its-kind product with preventive and curative properties for ‘Oral Mucositis’, which occurs in cancer patients undergoing chemotherapy and radiotherapy.  The product is developed by infusing herbal ingredients like Turmeric, Triphala, and Honey.  Oro-T also helps in treating Oral Submucous Fibrosis (OSF or OSMF), a chronic debilitating disease of the oral cavity characterized by inflammation and progressive fibrosis (hardening) of the underlying tissues of the mouth. OSF or OSMF is mainly associated with chronic Pan and Ghutka users.

“We, as a wellness company, are recognized worldwide for our pharmaceutical strengths, and our dedicated in-house team of scientists strives to develop products that help in improving a cancer patient’s quality of life in the best possible way. Oro-T has been introduced to delay the onset and reduce the severity of oral mucositis  or mouth ulcers in cancer patients undergoing radiotherapy or chemotherapy,” said Dr. Palaniyamma, Medical Advisor, The Himalaya Drug Company.

Curcumin, an active component in Turmeric, is one of the highly-researched molecules in the field of herbal medicine, and has potent anti-inflammatory and anti-tumor properties. Honey is validated to have wound-healing properties, while Triphala, due to its astringent property, acts as wound-healing agent too. The mouth rinse can also be purchased online through the Himalaya online store as well as the mobile app, stated the company.

“Despite being underreported and often under recognized, oral mucositis has a tremendous impact on the cancer patient and on the resources of the health care system. Oral mucositis is a common cause of dose delays, reductions, or interruptions, which limits the effectiveness of cancer therapy. Unfortunately, the currently available treatments are primarily palliative, and in many cases, only marginally effective,” Dr. Palaniyamma.

The clinical trials conducted for Oro-T at a few prominent hospitals have adjudged its effectiveness, attesting that the product is free from any kind of side effects on the body. The product is proven to improve the quality of life of a cancer patient through PROMs (Patient Reported Outcome Measures), a validated and globally accepted tool to analyze the quality of life. It is useful in reducing mouth ulcers, difficulty in speaking and restricted speech due to sores, difficulty in eating or swallowing hard/soft foods. It also helps in reducing pain and inflammation due to sore throat (pharyngitis).

 
[Close]